FDA authorizes Abbott's Libre Duo 10 Day, first wearable to continuously monitor both ketone and glucose levels in diabetes patients aged 2+, detecting diabetic ketoacidosis warning signs in real-time to prevent life-threatening emergencies.

FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar

FDA News Release New device can help people with diabetes detect warning signs of a dangerous complication before it becomes a medical emergency For Immediate Release: August 25, 2026 The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes. The Libre Duo 10 Day is the first wearable device in the U.S. that continuously monitors ketone levels, and the first in the world to c...